Sulacillin is a beta-lactamase inhibitor often administered in combination with ampicillin to treat bacterial infections of the respiratory tract, kidneys, urinary system, skin, and soft tissues. By protecting… Read more
Sulacillin is a beta-lactamase inhibitor often administered in combination with ampicillin to treat bacterial infections of the respiratory tract, kidneys, urinary system, skin, and soft tissues. By protecting the antibiotic from enzymatic degradation, it enhances therapeutic efficacy against resistant bacterial strains. This category offers high-quality reference standards for Sulacillin, including its active pharmaceutical ingredient, pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. Pharmaceutical and analytical laboratories require these materials to ensure the accuracy of impurity profiling, method validation, and routine quality control protocols. Utilizing authenticated reference materials for these specific compounds allows for the reliable quantification of degradation products and the assessment of drug stability throughout the manufacturing process, supporting compliance with rigorous industry standards for purity and safety.